Pfizer Stock Edges Into Buy Zone On AbbVie Deal For Humira Biosimilar – Investor’s Business Daily

This post was originally published on this site


Investor’s Business Daily

Pfizer Stock Edges Into Buy Zone On AbbVie Deal For Humira Biosimilar
Investor’s Business Daily
On the stock market today, AbbVie stock jumped 4.1% to 93.62. Pfizer stock rose 1.5% to 46.20. Shares edged above a buy point at 45.91 out of a flat base, though volume remained low. Meanwhile, pharmaceutical stocks collectively advanced a fraction

and more »

This post was originally published on *this site*